scholarly journals Neutralization of lymphokine-mediated antirickettsial activity of fibroblasts and macrophages with monoclonal antibody specific for murine interferon gamma.

1986 ◽  
Vol 51 (1) ◽  
pp. 355-359 ◽  
Author(s):  
T R Jerrells ◽  
J Turco ◽  
H H Winkler ◽  
G L Spitalny
1992 ◽  
Vol 46 (5-7) ◽  
pp. 316
Author(s):  
JW Greiner ◽  
C Nieroda ◽  
C Dansky-Ullmann ◽  
J Schlom

Hybridoma ◽  
1983 ◽  
Vol 2 (4) ◽  
pp. 439-449 ◽  
Author(s):  
EMILIA OLESZAK ◽  
HANS-JOACHIM FEICKERT ◽  
IMRE MECS ◽  
FLOYD FOX

2009 ◽  
Vol 90 (5) ◽  
pp. 1119-1123 ◽  
Author(s):  
Congrong Miao ◽  
Gertrud U. Radu ◽  
Hayat Caidi ◽  
Ralph A. Tripp ◽  
Larry J. Anderson ◽  
...  

Therapeutic treatment with a non-neutralizing monoclonal antibody (mAb) (131-2G) specific to respiratory syncytial virus (RSV) G glycoprotein mediates virus clearance and decreases leukocyte trafficking and interferon gamma (IFN-γ) production in the lungs of RSV-infected mice. Its F(ab′)2 component only mediates decreased leukocyte trafficking and IFN-γ production without reducing virus replication. Thus, this mAb has two independent actions that could facilitate treatment and/or prevention of RSV infection by reducing both virus replication and virus-induced pulmonary inflammation.


2003 ◽  
Vol 124 (4) ◽  
pp. A618
Author(s):  
Shiro Watanabe ◽  
Kenji Suzuki ◽  
Yusuke Kawauchi ◽  
Satoshi Yamagiwa ◽  
Hiroyuki Yoneyama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document